Get the Stockscreener App
0.40
4.68%
0.0179
After Hours:
.40
Spruce Biosciences Inc Stock (SPRB) Forecast
The Spruce Biosciences Inc (SPRB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.39, representing a +247.50% increase from the current price of $0.40. The highest analyst price target is $2.3914, and the lowest is $0.3886.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SPRB Price Target
Average 4.0372
(+909.29% Upside)
Is Spruce Biosciences Inc (SPRB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.54 | Neutral |
| STOCH(9,6) | 10.70 | Buy |
| STOCHRSI(14) | 27.88 | Neutral |
| MACD(12,26) | -0.0348 | Sell |
| ADX(14) | 24.78 | Neutral |
| William %R | -84.73 | Buy |
| CCI(14) | -68.30 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4233
Sell
|
0.419
Sell
|
| MA20 |
0.4726
Sell
|
0.4509
Sell
|
| MA50 |
0.5044
Sell
|
0.4827
Sell
|
| MA100 |
0.4796
Sell
|
0.5577
Sell
|
| MA200 |
0.6688
Sell
|
0.8721
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SPRB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on SPRB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.54 indicates that SPRB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.7 indicates that SPRB is oversold. This indicates that SPRB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.88 indicates that SPRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.78 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -68.3 indicates that SPRB is still oversold but not to an extreme extent.
Long-term SPRB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Spruce Biosciences Inc financial reports and earnings history, Spruce Biosciences Inc (SPRB) stock could reach $15.69 by 2030, $5.2189 by 2040 and $60.60 by 2050. See the projected annual prices until 2050 of the Spruce Biosciences Inc stock below:
- Spruce Biosciences Inc (SPRB) is expected to reach an average price of $13.25 in 2035, with a high prediction of $13.96 and a low estimate of $13.27. This indicates an $3,211% rise from the last recorded price of $0.40.
- Spruce Biosciences Inc (SPRB) stock is projected to chart a bullish course in 2040, with an average price target of $3.4963, representing an $774.07% surge from its current level. The forecast ranges from a conservative $4.0338 to a sky-high $5.2189.
- Our analysts predict Spruce Biosciences Inc (SPRB) to jump 15,395% by 2045, soaring from $61.68 to an average price of $61.98, potentially reaching $60.88. While $61.68 is the low estimate, the potential upside is significant.
- Spruce Biosciences Inc (SPRB) stock is expected to climb by 2050, reaching an average of $59.68, a $14,819% jump from its current level. However, a wide range of estimates exists, with high and low targets of $60.60 and $59.79, respectively, highlighting the market's uncertainty.
Spruce Biosciences Inc Stock (SPRB) Year by Year Forecast
Spruce Biosciences Inc Stock (SPRB) Price Forecast for 2025
Spruce Biosciences Inc Stock (SPRB) is expected to reach an average price of $4.0372 in 2025, with a high prediction of $7.6858 and a low estimate of $0.3886. This indicates an +909.29% rise from the last recorded price of $0.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.911 | $0.3886 | $2.3914 | +127.76% |
| February, 2025 | $2.3035 | $1.5041 | $1.1435 | +475.87% |
| March, 2025 | $3.396 | $2.7766 | $3.1228 | +748.99% |
| April, 2025 | $4.1515 | $3.5584 | $3.4115 | +937.88% |
| May, 2025 | $5.884 | $5.0297 | $5.0677 | +1,371% |
| June, 2025 | $6.0265 | $6.3437 | $6.168 | +1,407% |
| July, 2025 | $8.0521 | $6.3496 | $7.6858 | +1,913% |
| August, 2025 | $5.6545 | $6.6045 | $7.4252 | +1,314% |
| September, 2025 | $7.477 | $6.7376 | $7.157 | +1,769% |
| October, 2025 | $7.2426 | $7.4801 | $7.2563 | +1,711% |
| November, 2025 | $7.245 | $7.2402 | $7.1157 | +1,711% |
| December, 2025 | $6.7906 | $6.9975 | $6.9413 | +1,598% |
Spruce Biosciences Inc Stock (SPRB) Price Forecast for 2026
The predicted value for Spruce Biosciences Inc (SPRB) in 2026 is set at an average of $4.9513. Estimates vary from a peak of $7.0493 to a trough of $2.8533, indicating an +1,138% surge from the present price of $0.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.2831 | $6.8537 | $7.0431 | +1,721% |
| February, 2026 | $6.7255 | $6.9955 | $7.0493 | +1,581% |
| March, 2026 | $6.368 | $6.4468 | $6.5318 | +1,492% |
| April, 2026 | $5.9236 | $5.9705 | $6.1211 | +1,381% |
| May, 2026 | $5.4111 | $5.5829 | $5.5467 | +1,253% |
| June, 2026 | $5.5385 | $5.3692 | $5.3685 | +1,285% |
| July, 2026 | $5.8141 | $5.7779 | $5.651 | +1,354% |
| August, 2026 | $5.4766 | $5.6466 | $5.6103 | +1,269% |
| September, 2026 | $5.2822 | $5.259 | $5.3228 | +1,221% |
| October, 2026 | $3.6146 | $4.9546 | $5.0753 | +803.66% |
| November, 2026 | $2.8171 | $3.0671 | $3.1109 | +604.27% |
| December, 2026 | $3.1627 | $2.8533 | $3.0927 | +690.67% |
Spruce Biosciences Inc Stock (SPRB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Spruce Biosciences Inc (SPRB) is $1.4221, with a high forecast of $2.8389 and a low forecast of $0.00538. This indicates an +255.53% increase from the last price of $0.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9151 | $2.9351 | $2.8389 | +628.78% |
| February, 2027 | $2.7326 | $2.8714 | $2.7183 | +583.15% |
| March, 2027 | $2.1332 | $2.3332 | $2.5807 | +433.30% |
| April, 2027 | $1.9156 | $2.0356 | $2.0163 | +378.91% |
| May, 2027 | $1.9581 | $1.9981 | $1.895 | +389.53% |
| June, 2027 | $1.4687 | $1.5487 | $1.6912 | +267.17% |
| July, 2027 | $1.1962 | $1.2362 | $1.2768 | +199.04% |
| August, 2027 | $0.8986 | $0.8855 | $0.9093 | +124.66% |
| September, 2027 | $1.6842 | $1.0617 | $1.6444 | +321.05% |
| October, 2027 | $1.1367 | $1.3067 | $1.5504 | +184.17% |
| November, 2027 | $0.6291 | $0.7741 | $1.0198 | +57.29% |
| December, 2027 | $0.4353 | $0.00538 | $1.0946 | +8.82% |
Spruce Biosciences Inc Stock (SPRB) Price Forecast for 2028
In 2028, Spruce Biosciences Inc (SPRB) is projected to reach an average price of $5.4383, with a high projection of $10.84 and a low estimate of $0.0407. This indicates an +1,260% rise from the last price of $0.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6428 | $0.3222 | $2.6828 | +560.70% |
| February, 2028 | $3.8503 | $2.4897 | $4.2935 | +862.59% |
| March, 2028 | $0.2452 | $0.3042 | $4.5972 | -38.69% |
| April, 2028 | $0.1097 | $0.1277 | $0.2115 | -72.57% |
| May, 2028 | $7.8289 | $0.0407 | $10.84 | +1,857% |
| June, 2028 | $0.6912 | $0.4888 | $6.9436 | +72.79% |
| July, 2028 | $3.6438 | $6.9638 | $4.6013 | +810.94% |
| August, 2028 | $6.3749 | $6.9475 | $4.6149 | +1,494% |
| September, 2028 | $8.3699 | $7.0212 | $4.9274 | +1,992% |
| October, 2028 | $9.5148 | $8.1261 | $9.2148 | +2,279% |
| November, 2028 | $9.246 | $9.981 | $9.4073 | +2,211% |
| December, 2028 | $10.78 | $10.23 | $9.8309 | +2,595% |
Spruce Biosciences Inc Stock (SPRB) Price Forecast for 2029
The 2029 price forecast for Spruce Biosciences Inc Stock (SPRB) is $15.44 on average, with a high prediction of $18.10 and a low estimate of $12.78. This represents an +3,759% increase from the previous price of $0.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.03 | $12.78 | $12.88 | +3,158% |
| February, 2029 | $14.16 | $13.56 | $13.00 | +3,439% |
| March, 2029 | $14.98 | $14.56 | $14.78 | +3,645% |
| April, 2029 | $14.83 | $14.88 | $14.77 | +3,607% |
| May, 2029 | $16.87 | $15.63 | $16.12 | +4,117% |
| June, 2029 | $16.74 | $17.06 | $17.02 | +4,086% |
| July, 2029 | $18.32 | $17.00 | $18.10 | +4,479% |
| August, 2029 | $15.77 | $16.72 | $18.07 | +3,842% |
| September, 2029 | $17.32 | $16.79 | $17.00 | +4,231% |
| October, 2029 | $16.76 | $17.09 | $16.96 | +4,089% |
| November, 2029 | $16.49 | $16.68 | $16.56 | +4,023% |
| December, 2029 | $15.94 | $15.97 | $16.05 | +3,886% |
Spruce Biosciences Inc Stock (SPRB) Price Forecast for 2030
Spruce Biosciences Inc Stock (SPRB) is expected to reach an average price of $12.09 in 2030, with a high forecast of $15.69 and a low forecast of $8.4866. This signifies an +2,922% surge from the last price of $0.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $15.93 | $15.70 | $15.69 | +3,882% |
| February, 2030 | $15.10 | $15.37 | $15.61 | +3,675% |
| March, 2030 | $14.48 | $14.55 | $14.77 | +3,519% |
| April, 2030 | $13.69 | $13.81 | $14.16 | +3,323% |
| May, 2030 | $12.92 | $13.09 | $13.48 | +3,129% |
| June, 2030 | $12.78 | $12.78 | $12.69 | +3,094% |
| July, 2030 | $12.72 | $12.72 | $12.73 | +3,080% |
| August, 2030 | $12.11 | $12.28 | $12.44 | +2,928% |
| September, 2030 | $11.59 | $11.63 | $11.84 | +2,797% |
| October, 2030 | $9.6492 | $10.99 | $11.40 | +2,312% |
| November, 2030 | $8.5842 | $8.8342 | $9.0117 | +2,046% |
| December, 2030 | $8.7991 | $8.4866 | $8.3891 | +2,100% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):